Related Experiment Video
Updated: Sep 7, 2025
08:11
Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
Published on: July 6, 2013
12.9K
Visualized Cancer Immunotherapy with Engineered Salmonella typhimurium
1School of Biomedical Sciences, Hunan University, Changsha, China.
Methods in Molecular Biology (Clifton, N.J.)
|June 22, 2022
Summary
Genetically engineered Salmonella typhimurium expressing Vibrio vulnificus flagellin B (FlaB) effectively targets tumors and boosts cancer immunotherapy. This approach enhances safety and allows for visual tracking of treatment efficacy.
Area of Science:
- * Oncolytic virotherapy and cancer immunotherapy
- * Bacterial engineering and molecular biology
Background:
- * Genetically modified Salmonella typhimurium demonstrate tumor-specific colonization and growth inhibition.
- * Vibrio vulnificus flagellin B (FlaB) is a potent Toll-like receptor 5 (TLR5) agonist, acting as an effective adjuvant in cancer immunotherapy due to its high TLR5 binding affinity.
- * Current cancer immunotherapies require enhanced targeted delivery and safety profiles.
Purpose of the Study:
- * To engineer attenuated Salmonella typhimurium for enhanced targeted cancer immunotherapy.
- * To improve the safety profile of Salmonella-based cancer therapy.
- * To enable visualization of therapeutic progression using bioluminescence imaging.
Main Methods:
- * Construction of attenuated Salmonella typhimurium strains with a controlled expression system for flagellin B (FlaB).
- * Introduction of the lux operon for bioluminescence imaging.
- * Evaluation of tumor colonization, growth inhibition, and immune activation in preclinical models.
Main Results:
- * Engineered Salmonella typhimurium successfully colonized tumor tissues.
- * Controlled expression of FlaB enhanced anti-tumor activity and immune response.
- * Bioluminescence imaging allowed for real-time monitoring of bacterial distribution and therapeutic effects.
- * The modified bacteria exhibited improved safety profiles compared to wild-type strains.
Conclusions:
- * Attenuated Salmonella typhimurium engineered to express flagellin B (FlaB) represents a promising strategy for targeted cancer immunotherapy.
- * The controlled expression system and bioluminescence imaging offer enhanced safety and monitoring capabilities.
- * This dual-action approach holds potential for improving patient outcomes in cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652
01:30Cancer Vaccines
506
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
506